Tore Jensen

684 total citations
9 papers, 535 citations indexed

About

Tore Jensen is a scholar working on Immunology, Gastroenterology and Hematology. According to data from OpenAlex, Tore Jensen has authored 9 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Gastroenterology and 3 papers in Hematology. Recurrent topics in Tore Jensen's work include Celiac Disease Research and Management (4 papers), Immunotherapy and Immune Responses (2 papers) and Blood groups and transfusion (2 papers). Tore Jensen is often cited by papers focused on Celiac Disease Research and Management (4 papers), Immunotherapy and Immune Responses (2 papers) and Blood groups and transfusion (2 papers). Tore Jensen collaborates with scholars based in Norway, United States and Sweden. Tore Jensen's co-authors include Ludvig M. Sollid, Helene Arentz–Hansen, Knut E. A. Lundin, Øyvind Molberg, Anne Kjersti Uhlen, Melinda Ráki, Burkhard Fleckenstein, Olin D. Anderson, Stephen N. McAdam and Hanne Quarsten and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Tore Jensen

9 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tore Jensen Norway 6 347 194 114 108 82 9 535
Melinda Y. Hardy Australia 15 367 1.1× 261 1.3× 295 2.6× 29 0.3× 13 0.2× 34 722
Delia Zanzi Italy 15 473 1.4× 312 1.6× 424 3.7× 34 0.3× 14 0.2× 20 830
Franka Kahlenberg Germany 7 220 0.6× 144 0.7× 106 0.9× 19 0.2× 11 0.1× 9 352
Luis Sorell Cuba 13 97 0.3× 97 0.5× 60 0.5× 17 0.2× 12 0.1× 25 373
Graham Radford-Smith Australia 9 132 0.4× 206 1.1× 83 0.7× 4 0.0× 16 0.2× 14 432
Nicola Giardullo Italy 15 450 1.3× 250 1.3× 228 2.0× 44 0.4× 5 0.1× 26 980
Lenka Palová Jelínková Czechia 9 176 0.5× 119 0.6× 144 1.3× 10 0.1× 3 0.0× 15 416
Stefan Schreiber Germany 5 37 0.1× 130 0.7× 232 2.0× 8 0.1× 33 0.4× 9 504
Nicolas Montcuquet France 10 186 0.5× 166 0.9× 274 2.4× 3 0.0× 14 0.2× 16 555
Martina Wiesner Netherlands 9 155 0.4× 159 0.8× 160 1.4× 8 0.1× 6 0.1× 9 365

Countries citing papers authored by Tore Jensen

Since Specialization
Citations

This map shows the geographic impact of Tore Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tore Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tore Jensen more than expected).

Fields of papers citing papers by Tore Jensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tore Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tore Jensen. The network helps show where Tore Jensen may publish in the future.

Co-authorship network of co-authors of Tore Jensen

This figure shows the co-authorship network connecting the top 25 collaborators of Tore Jensen. A scholar is included among the top collaborators of Tore Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tore Jensen. Tore Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Nissen‐Meyer, Lise Sofie Haug, et al.. (2022). Screening for antibodies to HLA class I in apheresis donors following Covid‐19 or SARS-CoV-2 vaccination. Transfusion and Apheresis Science. 61(5). 103567–103567. 3 indexed citations
2.
Jensen, Tore, et al.. (2019). The novel HLA‐A*03 variant, HLA‐A*03:08:01:02, detected by sequencing‐based typing. HLA. 94(1). 60–61. 4 indexed citations
3.
Jensen, Tore, et al.. (2019). The novel HLA‐A*01 variant, HLA‐A*01:308N, detected by sequencing‐based typing. HLA. 94(3). 312–312. 2 indexed citations
4.
Dahl, Jesper, Erle Refsum, Maria Therese Ahlén, et al.. (2017). Unraveling the role of maternal anti-HLA class I antibodies in fetal and neonatal thrombocytopenia—Antibody specificity analysis using epitope data. Journal of Reproductive Immunology. 122. 1–9. 13 indexed citations
5.
Ge, Yubin, Mark Stout, Tore Jensen, et al.. (2005). GATA1, Cytidine Deaminase, and the High Cure Rate of Down Syndrome Children With Acute Megakaryocytic Leukemia. JNCI Journal of the National Cancer Institute. 97(3). 226–231. 82 indexed citations
6.
Molberg, Øyvind, Anne Kjersti Uhlen, Tore Jensen, et al.. (2005). Mapping of gluten T-cell epitopes in the bread wheat ancestors: Implications for celiac disease. Gastroenterology. 128(2). 393–401. 207 indexed citations
7.
Molberg, Øyvind, Tore Jensen, Knut E. A. Lundin, et al.. (2003). Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease. Gastroenterology. 125(2). 337–344. 111 indexed citations
8.
Quarsten, Hanne, Stephen N. McAdam, Tore Jensen, et al.. (2001). Staining of Celiac Disease-Relevant T Cells by Peptide-DQ2 Multimers. The Journal of Immunology. 167(9). 4861–4868. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026